What is the share price of Religare Enterprises Ltd (RELIGARE) today?
The share price of RELIGARE as on 16th November 2026 is ₹226.45. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Religare Enterprises Ltd (RELIGARE) share?
The past returns of Religare Enterprises Ltd (RELIGARE) share are- Past 1 week: 4.24%
- Past 1 month: 4.63%
- Past 3 months: -0.18%
- Past 6 months: 2.85%
- Past 1 year: -10.10%
- Past 3 years: 5.68%
- Past 5 years: 37.24%
What are the peers or stocks similar to Religare Enterprises Ltd (RELIGARE)?
The peers or stocks similar to Religare Enterprises Ltd (RELIGARE) include:What is the market cap of Religare Enterprises Ltd (RELIGARE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Religare Enterprises Ltd (RELIGARE) is ₹8064.87 Cr as of 16th November 2026.What is the 52 week high and low of Religare Enterprises Ltd (RELIGARE) share?
The 52-week high of Religare Enterprises Ltd (RELIGARE) is ₹280 and the 52-week low is ₹196.51.What is the PE and PB ratio of Religare Enterprises Ltd (RELIGARE) stock?
The P/E (price-to-earnings) ratio of Religare Enterprises Ltd (RELIGARE) is 93.82. The P/B (price-to-book) ratio is 2.08.Which sector does Religare Enterprises Ltd (RELIGARE) belong to?
Religare Enterprises Ltd (RELIGARE) belongs to the Financials sector & Investment Banking & Brokerage sub-sector.How to buy Religare Enterprises Ltd (RELIGARE) shares?
You can directly buy Religare Enterprises Ltd (RELIGARE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Religare Enterprises Ltd
RELIGARE Share Price
NSERELIGARE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
RELIGARE Performance & Key Metrics
RELIGARE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -205.58 | 2.08 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 17.36 | 2.27 | 1.16% |
RELIGARE Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
RELIGARE Company Profile
Religare Enterprises Limited is a financial services company engaged in the business of broking in securities and commodities, lending and investments, financial advisory services, portfolio management services, asset management and insurance etc.
RELIGARE Sentiment Analysis
RELIGARE Sentiment Analysis
RELIGARE Stock Summary · August 2026
Management said the quarter was marked by strong growth at Care Health alongside clear progress in digital execution, even as profitability and capital needs remained under pressure. Gross written premium rose 37% year on year in Q1 FY27, while Ind AS insurance revenue increased 28% to INR2,947 crore and profit before tax improved to INR163 crore, with ROE at 5.2%. Management highlighted that proprietary channels are contributing nearly half of premium, nearly all policies are now issued digitally, and more than 85% of cashless claims are resolved within 30 minutes, supporting mix and service improvements. At the same time, the combined ratio stayed elevated at 102.6%, mainly because of upfront claims in the corporate wellness book and a INR66 crore non-attributable expense item, though management reiterated its goal of bringing the ratio to 100% over the next two years. Capital support also remained important, with solvency at 1.58% at end-June and a recent INR200 crore sub-debt raise helping address the immediate position. Management’s near-term message was cautious but constructive: growth should continue, operating ratios should improve with scale, and the demurrer issue with RBI remains unresolved.
RELIGARE Stock Growth Drivers
RELIGARE Stock Growth Drivers
9Strong Health Insurance Growth and Market Share Gains
Care Health Insurance delivered robust top-line momentum, with gross written premium and full-premium growth both
Improving Insurance Profitability, Efficiency, and Digital Execution
The insurance business showed clear operating improvement, with profit before tax rising meaningfully year over
RELIGARE Stock Challenges
RELIGARE Stock Challenges
6Regulatory setback on demerger approval
The company’s request for demerger approval has not been acceded to by the regulator, creating
Weak consolidated and holding-company profitability
Quarterly performance deteriorated year on year despite revenue growth, with consolidated total income of about
RELIGARE Forecast
RELIGARE Forecasts
RELIGARE
RELIGARE
Income
Balance Sheet
Cash Flow
RELIGARE Income Statement
RELIGARE Income Statement
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | sep 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,714.43 | 1,970.97 | 1,670.24 | 2,049.82 | 1,871.69 | 2,088.92 | 2,067.93 | 2,473.30 | 2,358.43 | 2,389.75 | ||||||||||
| Operating & Other expenses | 1,665.89 | 1,888.85 | 1,735.06 | 1,810.37 | 1,853.41 | 2,019.32 | 2,160.23 | 2,334.54 | 2,417.45 | 2,494.23 | ||||||||||
| EBITDA | 48.54 | 82.12 | -64.82 | 239.45 | 18.28 | 69.60 | -92.30 | 138.76 | -59.02 | -104.48 | ||||||||||
| Depreciation/Amortization | 15.89 | 14.69 | 14.08 | 17.35 | 12.55 | 12.14 | 10.79 | 11.58 | 17.70 | 23.30 | ||||||||||
| PBIT | 32.65 | 67.43 | -78.90 | 222.10 | 5.73 | 57.46 | -103.09 | 127.18 | -76.72 | -127.78 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | 32.65 | 67.43 | -78.90 | 222.10 | 5.73 | 57.46 | -103.09 | 127.18 | -76.72 | -127.78 | ||||||||||
| Taxes & Other Items | 14.65 | 16.11 | -35.89 | 123.63 | -4.49 | 18.62 | -57.78 | 44.96 | -50.55 | -77.81 | ||||||||||
| Net Income | 18.00 | 51.32 | -43.01 | 98.47 | 10.22 | 38.84 | -45.31 | 82.22 | -26.17 | -49.97 | ||||||||||
| EPS | 0.55 | 1.55 | -1.30 | 3.00 | 0.31 | 1.17 | -1.37 | 2.47 | -0.78 | -1.45 |
RELIGARE Company Updates
Investor Presentation
Investor Presentation
RELIGARE Stock Peers
RELIGARE Past Performance & Peer Comparison
RELIGARE Past Performance & Peer Comparison
FinancialsInvestment Banking & Brokerage
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Religare Enterprises Ltd | 93.82 | 2.08 | — |
| Billionbrains Garage Ventures Ltd | 67.07 | 14.48 | — |
| 360 One Wam Ltd | 41.50 | 5.13 | 0.97% |
| Angel One Ltd | 34.90 | 5.19 | 7.06% |
RELIGARE Stock Price Comparison
Compare RELIGARE with any stock or ETFRELIGARE Holdings
RELIGARE Shareholdings
RELIGARE Promoter Holdings Trend
RELIGARE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
RELIGARE Institutional Holdings Trend
RELIGARE Institutional Holdings Trend
In last 3 months, retail holding in the company has decreased by 1.02%
In last 3 months, foreign institutional holding of the company has almost stayed constant
RELIGARE Shareholding Pattern
RELIGARE Shareholding Pattern
RELIGARE Shareholding History
RELIGARE Shareholding History
Mutual Funds Invested in RELIGARE
Mutual Funds Invested in RELIGARE
No mutual funds holding trends are available
Top 5 Mutual Funds holding Religare Enterprises Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4012% | Percentage of the fund’s portfolio invested in the stock 4.22% | Change in the portfolio weight of the stock over the last 3 months -1.42% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 6/77 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1628% | Percentage of the fund’s portfolio invested in the stock 0.61% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/316 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1580% | Percentage of the fund’s portfolio invested in the stock 8.48% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 3/90 (0) |
Compare 3-month MF holding change on Screener
smallcases containing RELIGARE stock
smallcases containing RELIGARE stock
Looks like this stock is not in any smallcase yet.
RELIGARE Events
RELIGARE Events
RELIGARE Dividend Trend
RELIGARE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
RELIGARE Dividend Trend
RELIGARE has not given any dividends in last 5 years
RELIGARE Dividends
RELIGARE Dividends
RELIGARE Stock News & Opinions
RELIGARE Stock News & Opinions
Religare Enterprises Ltd share price ticked higher by 0.22% to Rs 231.35 after the company's net profit jumped 107.94% to Rs 97.69 crore, while revenue from operations improved marginally 1.13% to Rs 359.18 crore in Q2FY27 over Q2FY26. The market capitalization of Investment Company industry group stocks on BSE stood at Rs 4.35 lakh crore, heading higher 12.79%. It has improved by 1.93% over last one week and dipped slightly by 3.35% in last one month while the market capitalization of Religare Enterprises Ltd has softened by 0.96% and 1.38% in the same period respectively. Profit before tax (PBT) of Religare Enterprises Ltd stood at Rs 127.79 crore in Q2 FY27, crashing by 322.44% year-on-year, and surging by 66.55% quarter-on-quarter. EBITDA came in at Rs 123 crore, tanking 372.85% YoY and rallying 60.44% sequentially. Total expenses inched up 3.38% to Rs 2517.54 crore in Q2FY27 over Q2FY26. During the quarter, employee benefits expense was at Rs 337.59 crore, easing 4.04% YoY. For FY26, revenue from operations advanced 17.43% to Rs 1156.18 crore, while net profit witnessed a sharp fall of 59.97% to Rs 73.16 crore, compared to previous FY. EBITDA jumped by 23473% to Rs 65.36 crore, and PBT collapsed by 64.13% to Rs 87.26 crore compared to previous FY. Religare Enterprises Ltd tumbled by 11.50% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.03% during the same period.
Religare Enterprises Limited will hold a board meeting on November 12, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter and year-to-date ended September 30, 2026, along with a limited review report from the company’s auditors. The trading window for the company’s shares was closed from October 1, 2026, and will remain closed until November 14, 2026, following the announcement of the financial results.
Religare Enterprises Limited said the Reserve Bank of India has approved the appointments of Dr. Anand Chand Burman, Mr. Aditya Chand Burman, Mr. Mohit Burman, and Mr. Jimeet Vipul Modi as additional directors to the company’s board, effective November 3, 2026. The appointments, initially announced November 13, 2025, are for a period not exceeding five years.
Religare Enterprises Limited announced that its board of directors approved the appointment of Ms. Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer, effective October 31, 2026, designating her as a Key Managerial Person.
Religare Enterprises Limited informed the National Stock Exchange of India Ltd and BSE Limited that KFin Technologies Limited, its registrar and share transfer agent, has confirmed compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Religare Enterprises Limited announced that its Investment, Borrowing and Share Allotment Committee has approved the allotment of 22,000 equity shares following the exercise of stock options under the Religare Enterprises Limited - Employee Stock Option Plan 2019, increasing the company’s issued, subscribed, and paid-up equity capital from Rs 3,44,73,37,420 divided into 34,47,33,742 equity shares to Rs 3,44,75,57,420 divided into 34,47,55,742 equity shares.
Religare Enterprises Limited will close its trading window for share transactions for its stakeholders from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Religare Enterprises Limited announced that its members approved the re-designation of Mr. Arjun Lamba as Managing Director, effective August 12, 2026, at the company’s 42nd Annual General Meeting held on September 24, 2026.
Religare Enterprises Limited announced that its Nomination and Remuneration Committee granted 13,195 stock options under the Religare Enterprises Limited Employee Stock Option Plan 2019, with a pricing formula of Rs 227.35 per equity share, to eligible employees on August 12, 2026. The options will vest in 5 equal annual installments, with the first installment of 2,639 options vesting after one year, and may be exercised within eight years from the vesting date.
Religare Enterprises Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from its auditors. The trading window for the company's shares was closed from July 1, 2026, and will remain closed until 48 hours after the declaration of the unaudited financial results, which is August 14, 2026.
Over the last 5 years, revenue has grown at a yearly rate of 27.4%, vs industry avg of 23.44%
Over the last 5 years, market share increased from 8.63% to 10.2%